ASX:EVEFood, Beverage & TobaccoPackaged Foods & Meats
EVE HEALTH GROUP ORD
$0.028
$0.001 (3.45%)
Day Range
$0.024 - $0.028
52 Week Range
$0.017 - $0.044
Volume
825.41K
Avg Volume (10D)
654.95K
Market Cap
$9.79M
Price Chart
Market Statistics
Open$0.028
Previous Close$0.029
Day High$0.028
Day Low$0.024
52 Week High$0.044
52 Week Low$0.017
Valuation
Market Cap9.79M
Shares Outstanding349.58M
Price to Book2.20
Trading Activity
Volume825.41K
Value Traded21.32K
Bid$0.028 × 24,500
Ask$0.030 × 197,799
Performance
1 Day-3.33%
5 Day-6.45%
13 Week38.10%
52 Week-27.50%
YTD38.10%
Technical Indicators
RSI (14)52.76
50-Day SMA$0.024
200-Day SMA$0.027
Latest News
Biotechnology
EVE Health Appoints New CEO to Lead Company Through Next Phase of Growth
EVE Health appoints COO Ben Rohr as new CEO to drive next growth phase and accelerate commercialisation; Damian Wood shifts to regulatory/medical affairs.
1 min read
Biotechnology
EVE Health Increases Capital Raising to $1.3m with $400,000 Cornerstone Investment
EVE Health Group lifts capital raise to $1.3m with $400k cornerstone, signalling reformulated-drug strategy and new science adviser amid Libbo launch.
1 min read
Biotechnology
EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline
EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.
1 min read
Biotechnology
EVE Health Advances Reformulated Drugs Targeting Sexual Health and Cardiovascular Markets
EVE Health advances reformulated ED/PE sprays and Apixaban delivery, expanding its sexual health and cardiovascular pipeline.
2 min read